These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8099951)

  • 1. Reduction of dopamine synthesis inhibition by dopamine autoreceptor activation in striatal synaptosomes with in vivo reserpine administration.
    Tissari AH; Lillgäls MS
    J Neurochem; 1993 Jul; 61(1):231-8. PubMed ID: 8099951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synaptosomal dopamine autoreceptors: sensitivity changes after in vitro and in vivo treatments.
    Tissari AH
    Pharmacol Res Commun; 1988 Nov; 20(11):1001-11. PubMed ID: 2853876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase of dopamine synthesis in synaptosomes from rats treated with neuroleptics or reserpine.
    Tissari AH
    Med Biol; 1982 Feb; 60(1):38-41. PubMed ID: 6121960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Striatal synaptosomal dopamine synthesis: evidence against direct regulation by an autoreceptor mechanism.
    Compton DR; Johnson KM
    Eur J Pharmacol; 1985 Apr; 110(2):157-62. PubMed ID: 2859213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presynaptic dopamine autoreceptors control tyrosine hydroxylase activation in depolarized striatal dopaminergic terminals.
    el Mestikawy S; Glowinski J; Hamon M
    J Neurochem; 1986 Jan; 46(1):12-22. PubMed ID: 2866232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine synthesis in synaptosomes: relation of autoreceptor functioning to pH, membrane depolarization, and intrasynaptosomal dopamine content.
    Saller CF; Salama AI
    J Neurochem; 1984 Sep; 43(3):675-88. PubMed ID: 6747629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is inhibition of striatal synaptosomal tyrosine hydroxylation by dopamine agonists a measure of dopamine autoreceptor function?
    Fowler CJ; Thorell G; Andersson M; Magnusson O
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Oct; 331(1):12-9. PubMed ID: 2866447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that adenosine A2 and dopamine autoreceptors antagonistically regulate tyrosine hydroxylase activity in rat striatal synaptosomes.
    Onali P; Olianas MC; Bunse B
    Brain Res; 1988 Jul; 456(2):302-9. PubMed ID: 2905190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presynaptic inhibition of dopamine synthesis in rat striatal tissue by enantiomeric mono- and dihydroxyaporphines.
    Booth RG; Baldessarini RJ; Kula NS; Gao Y; Zong R; Neumeyer JL
    Mol Pharmacol; 1990 Jul; 38(1):92-101. PubMed ID: 1973525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apomorphine enantiomers' effects on dopamine metabolism: receptor and non-receptor related actions.
    Saller CF; Salama AI
    Eur J Pharmacol; 1986 Feb; 121(2):181-8. PubMed ID: 3699091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions between endogenous dopamine and dopamine agonists at release modulatory receptors: multiple effects of neuronal uptake inhibitors on transmitter release.
    Hoffmann IS; Talmaciu RK; Cubeddu LX
    J Pharmacol Exp Ther; 1986 Aug; 238(2):437-46. PubMed ID: 2942676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic cocaine treatment impairs the regulation of synaptosomal 3H-DA release by D2 autoreceptors.
    Yi SJ; Johnson KM
    Pharmacol Biochem Behav; 1990 Jul; 36(3):457-61. PubMed ID: 1974064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative dopamine-cholinergic mechanisms in the olfactory tubercle and the striatum: effects of metoclopramide.
    Suarez-Roca H; Lovenberg T; Cubeddu LX
    J Pharmacol Exp Ther; 1987 Dec; 243(3):840-51. PubMed ID: 3320346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of dopamine synthesis in striatal synaptosomes by lisuride: stereospecific reversal by (-)-sulpiride.
    Tissari AH; Atzori L; Galdieri MT
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Feb; 322(1):89-91. PubMed ID: 6843693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine autoreceptor regulation of the kinetic state of striatal tyrosine hydroxylase.
    Strait KA; Kuczenski R
    Mol Pharmacol; 1986 Jun; 29(6):561-9. PubMed ID: 2872588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of reserpine and tetrabenazine on rat striatal synaptosomal dopamine biosynthesis and synaptosomal dopamine pools.
    Kuczenski R
    J Pharmacol Exp Ther; 1977 May; 201(2):357-67. PubMed ID: 870679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of the Ca++-evoked release of [3H]dopamine from striatal synaptosomes by dopamine (D2) agonists and antagonists.
    Bowyer JF; Weiner N
    J Pharmacol Exp Ther; 1987 Apr; 241(1):27-33. PubMed ID: 3572788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The accumulation of dopamine into striatal synaptosomes, and its inhibition: comparison of crude, partially purified and purified synaptosomal preparations.
    Tuomisto J; Tuomisto L
    Med Biol; 1979 Aug; 57(4):238-45. PubMed ID: 513880
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
    Thomas KL; Rose S; Jenner P; Marsden CD
    Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores.
    Parker EM; Cubeddu LX
    J Pharmacol Exp Ther; 1986 Apr; 237(1):179-92. PubMed ID: 3007736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.